News: 20162019-02-11T20:15:21-06:00

News: 2016

Shore Capital Partners announced sale of ClearPath Diagnostics

October 3, 2016 – Shore Capital Partners ("Shore Capital"), a healthcare-focused private equity firm, today announced the sale of ClearPath Diagnostics ("ClearPath"), a leading provider of laboratory diagnostic services in the Northeastern United States, to Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH), the world's leading healthcare diagnostics company. Shore Capital partnered with ClearPath's founding pathologists, Dr. Michael Jozefczyk and Dr. Michael Mazur, to drive the company's expansion beyond the local Syracuse, New York market. Together, Shore Capital and ClearPath executed a growth strategy that extended the company's geographic reach to four states and expanded the service menu to include new cutting-edge [...]

Shore Capital Partners announced sale of Fast Pace Urgent Care

August 23, 2016 – Shore Capital Partners (“Shore Capital”) a healthcare-focused private equity firm, is pleased to announce the sale of Fast Pace Urgent Care (“Fast Pace”), a leading provider of urgent care services throughout rural Tennessee and Kentucky, to Revelstoke Capital Partners. In December 2012, Shore Capital partnered with Fast Pace founders, Stan Bevis and Reams Powers, to help grow their initial seven urgent care locations. Shore Capital and Fast Pace together executed an accelerated growth plan and expanded the business from seven to 36 clinics in approximately three and a half years. The growth came primarily through de novo expansion as [...]